AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
Condition:   Advanced Non-small-cell Lung Cancer Interventions:   Drug: AK112;   Drug: AK104;   Drug: caboplatin;   Drug: paclitaxel;   Drug: pemetrexed;   Drug: Docetaxel Sponsor:   Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials